Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Viral nucleic acid is extracted from clinical specimens. Primers are directed to the large T antigen gene, which is a conserved sequence specific for BK virus (BKV). This assay detects only BKV; it does not detect JC virus or Simian virus 40 (SV-40) (other polyoma viruses). Amplification and monitoring of the development of target nucleic acid sequences occurs after the annealing step during polymerase chain reaction (PCR) cycling. This automated PCR system can rapidly detect (30-40 minutes) amplicon development through stringent air-controlled temperature cycling and capillary cuvettes. The detection of amplified products is based on the fluorescence resonance energy transfer (FRET) principle. For FRET product detection, a hybridization probe with a donor fluorophore, fluorescein, on the 3'-end is excited by an external light source and emits light that is absorbed by a second hybridization probe with an acceptor fluorophore, LC-Red 640, at the 5'-end. The acceptor fluorophore then emits a light of a different wavelength that can be measured with a signal that is proportional to the amount of specific PCR product. Quantitative standards are used to develop a standard curve. Specimens with unknown levels of BKV DNA are then compared to the standard curve to determine the copy level of the virus. Reportable range is from 1,600 IU/mL to 16,000,000 IU/mL.(Unpublished Mayo method)
Monday through Saturday; Varies